Method and kit for detecting five immunosuppressants in dried blood spot

An immunosuppressant and dried blood film technology, which is applied in the field of detection of five immunosuppressants in dried blood film, can solve the problem of increasing the physiological burden and economic burden of patients and their families, the inability to monitor the five kinds of immunosuppressant therapeutic drugs, and not including Mycophenolic acid and other problems, to achieve the effect of facilitating individualized drug regimens, saving operating time, and convenient operation

Pending Publication Date: 2021-04-27
BGI CLINICAL LAB (SHENZHEN) CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The analytes detected by the kits of the existing LC-MS / MS method are not comprehensive, including only four immunosuppressants CsA, Tac, Sir, and Ever, and do not contain mycophenolic acid (MPA), which is commonly used in clinical practice. Inability to perform concurrent therapeutic drug monitoring of five immunosuppressants commonly involved
[0005] At the same time, it is worthy of our attention that during the period of immunosuppressant TDM, whole blood needs to be collected multiple times, which increases the physiological and economic burden of patients and their families.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and kit for detecting five immunosuppressants in dried blood spot
  • Method and kit for detecting five immunosuppressants in dried blood spot
  • Method and kit for detecting five immunosuppressants in dried blood spot

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] Example 1. Rapid detection kit and detection method for immunosuppressants in dried blood slices

[0093] The rapid detection indicators of the kit provided in this example include: cyclosporine A, tacrolimus, sirolimus, everolimus and mycophenolic acid.

[0094] The contents of the rapid detection kit for immunosuppressants in dried blood slices provided in the present invention include:

[0095] Table 1 Kit Composition

[0096]

[0097]

[0098] Store the kit at 2-8°C in the dark.

[0099] Explanation: Since tacrolimus is relatively stable in the process of pretreatment preparation and mass spectrometry detection, it is less disturbed, and the external standard method is used for quantification, and the detection results meet the requirements. Under the condition that the detection requirements are met, the external standard method can be used to quantify tacrolimus, which can reduce the cost of sample detection. Therefore, the tacrolimus internal standard is...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a liquid chromatography-tandem mass spectrometry method and a kit for accurately determining the content of five immunosuppressants in a dry blood spot. The method comprises the following steps: 1) uniformly mixing an internal standard working solution with an organic solvent to obtain an extracting solution; 2) extracting the dry blood spot of the sample to be detected by using the extracting solution, centrifuging to obtain a supernatant I after the extraction is finished, blow-drying the supernatant I with nitrogen, re-dissolving to obtain a solution II, whirling, centrifuging, and detecting; and 3) detecting the solution II by adopting a liquid chromatography-tandem mass spectrometry method, wherein the internal standard working solution contains a cyclosporin A isotope internal standard substance, an everolimus isotope internal standard substance, a sirolimus isotope internal standard substance and a mycophenolic acid isotope mixed internal standard substance. According to the method, during detection, five immunosuppressants can be quantified at a time only by 6 microliters of a blood sample, the pretreatment method is simple and rapid, the operation time is saved, the immunosuppressive blood concentration can be effectively monitored according to the indexes, and more complete treatment medication information can be obtained in time.

Description

technical field [0001] The invention relates to a method for detecting five kinds of immunosuppressants in dried blood slices and a kit thereof. Background technique [0002] Immunosuppressants are a class of chemical or biological substances that reduce tissue damage by inhibiting cellular and humoral immune responses, and can inhibit abnormal immune responses in the body. They are mainly used in the treatment of organ transplantation anti-rejection and autoimmune diseases [1] . Since the development of immunosuppressants in the 1970s, the immunosuppressants currently being clinically used can basically be divided into five categories. The first category is cytokine inhibitors, such as cyclosporine A, tacrolimus, sirolimus, everolimus and so on. The second category is DNA synthesis inhibitors, such as azathioprine, mycophenolic acid, mizoribine and so on. The third category is glucocorticoids, such as prednisone and methylprednisone. The fourth category is anti-lymphocy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/88G01N30/06
CPCG01N30/06G01N30/88
Inventor 云莉芬廖云莉饶维桥任艳訾金林梁
Owner BGI CLINICAL LAB (SHENZHEN) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products